AlerhandSCassellaCKoyfmanA. Stevens-Johnson syndrome and toxic epidermal necrolysis in the pediatric population: a review. Pediatr Emerg Care. 2016;32(7):472-476. doi:10.1097/PEC.0000000000000840.
2.
NaegeleDSekulaPPaulmannMMockenhauptM. Incidence of epidermal necrolysis: results of the German registry. J Invest Dermatol. 2020;140(12):2525-2527. doi:10.1016/j.jid.2020.03.968.
3.
RamienMGoldmanJL. Pediatric SJS-TEN: where are we now?F1000Res. 2020;9:F1000 Faculty Rev-982. doi:10.12688/f1000research.20419.1.
4.
LeviNBastuji-GarinSMockenhauptM, et al. Medications as risk factors of Stevens-Johnson syndrome and toxic epidermal necrolysis in children: a pooled analysis. Pediatrics. 2009;123(2):e297-e304. doi:10.1542/peds.2008-1923.
5.
ArantesLBReisCSNovaesAGCarvalhoMRGöttemsLBDNovaesMRCG. Stevens-Johnson syndrome and toxic epidermal necrolysis: epidemiological and clinical outcomes analysis in public hospitals. An Bras Dermatol. 2017;92(5):661-667. doi:10.1590/abd1806-4841.20176610.
6.
QuirkeKPBeckAGamelliRLMosierMJ. A 15-year review of pediatric toxic epidermal necrolysis. J Burn Care Res. 2015;36(1):130-136. doi:10.1097/BCR.0000000000000208.
7.
KhorAHLimKSTanCT, et al. HLA-A*31:01 and HLA-B*15:02 association with Stevens–Johnson syndrome and toxic epidermal necrolysis to carbamazepine in a multiethnic Malaysian population. Pharmacogenet Genomics. 2017;27(7):275-278. doi:10.1097/FPC.0000000000000287.
8.
LalosevicJNikolicMGajic-VeljicMSkiljevicDMedenicaL. Stevens-Johnson syndrome and toxic epidermal necrolysis: a 20-year single-center experience. Int J Dermatol. 2015;54(8):978-984. doi:10.1111/ijd.12702.
9.
YamaneYMatsukuraSWatanabeY, et al. Retrospective analysis of Stevens-Johnson syndrome and toxic epidermal necrolysis in 87 Japanese patients—treatment and outcome. Allergol Int. 2016;65(1):74-81. doi:10.1016/j.alit.2015.09.001.
10.
Léauté-LabrèzeCLamireauTChawkiDMalevilleJTaïebA. Diagnosis, classification, and management of erythema multiforme and Stevens–Johnson syndrome. Arch Dis Child. 2000;83(4):347-352. doi:10.1136/abc.83.4.347.
11.
MazoriDRNagarajanSGlickSA. Recurrent reactive infectious mucocutaneous eruption (RIME): insights from a child with three episodes. Pediatr Dermatol2020;37(3):545-547. doi:10.1111/pde.14142.
12.
PohjanpeltoPPettayO. Isolation of adenovirus from a skin vesicle and cerebrospinal fluid from a patient suffering from Stevens-Johnson syndrome. Acta Pathol Microbiol Scand. 1967;70(4):632.
13.
TingHCAdamBA. Stevens-Johnson syndrome: a review of 34 cases. Int J Dermatol1985;24(9):587-591. doi:10.1111/j.1365-4362.1985.tb05857.x.
14.
StrömJ. Aetiology of febrile mucocutaneous syndromes with special reference to the provocative role of infections and drugs. Acta Med Scand. 1977;201(1–2):131-136.
15.
KiernanJPSchanzlinDJLeveilleAS. Stevens-Johnson syndrome associated with adenovirus conjunctivitis. Am J Ophthalmol. 1981;92(4):543-545. doi:10.1016/0002-9394(81)90648-6.
CremerNEHoffmanMLennetteEH. Analysis of antibody assay methods and classes of viral antibodies in serodiagnosis of cytomegalovirus infection. J Clin Microbiol. 1978;8(2):153-159.
18.
Gámez-GonzálezLBPeña-VarelaCRamírez-LópezJMYamazaki-NakashimadaMA. Adenoviral-induced rash and mucositis: expanding the spectrum of reactive infectious mucocutaneous eruption. Pediatr Dermatol. 2020;38:306–308. doi:10.1111/pde.14419.
19.
CanavanTNMathesEFFriedenIShinkaiK. Mycoplasma pneumoniae-induced rash and mucositis as a syndrome distinct from Stevens-Johnson syndrome and erythema multiforme: a systematic review. J Am Acad Dermatol. 2015;72(2):239-245. doi:10.1016/j.jaad.2014.06.026.
20.
PaulmannMMockenhauptM. Fever in Stevens–Johnson syndrome and toxic epidermal necrolysis in pediatric cases. Pediatr Infect Dis J2017;36(5):513-515. doi:10.1097/INF.0000000000001571.
21.
PillayRFernandoLS. The importance of distinguishing mycoplasma pneumoniae-induced rash and mucositis (MIRM) and Stevens-Johnson syndrome in a clinical setting. Hematol Med Oncol. 2020;5:1-3. doi:10.15761/HMO.1000209.
22.
SassolasBHaddadCMockenhauptM, et al. ALDEN, an algorithm for assessment of drug causality in Stevens–Johnson Syndrome and toxic epidermal necrolysis: comparison with case–control analysis. Clin Pharmacol Ther. 2010;88(1):60-68. doi:10.1038/clpt.2009.252.
AberleSWAberleJHSteiningerCMatthes-MartinSPracherEPopow-KrauppT. Adenovirus DNA in serum of children hospitalized due to an acute respiratory adenovirus infection. J Infect Dis. 2003;187(2):311-314. doi:10.1086/367808.
